Ovarian cancer diagnostics company, Cleo Diagnostics Limited (ASX:COV) (CLEO, or the Company) is pleased to announce the publication of a milestone article on its blood test for the accurate and early detection of ovarian cancer. Highlights A benchmarking study comparing CLEO’s ovarian cancer blood test against ultrasound has been published…
Levi & Korsinsky notifies investors that it has commenced an investigation of Roblox Corporation (‘Roblox’) (NYSE:RBLX) concerning possible violations…
Global central banks held more than 36,699 metric tons (MT) of gold in their reserves as of year-end 2023.…
Metals Acquisition (MAC) (NYSE:MTAL,ASX:MAC) has signed a strategic investment deal with Polymetals Resources (ASX:POL), which is working to restart…